Evaluation of the PrimeCapture CMV DNA detection plate system for detection of cytomegalovirus in clinical specimens
- PMID: 10405406
- PMCID: PMC85289
- DOI: 10.1128/JCM.37.8.2587-2591.1999
Evaluation of the PrimeCapture CMV DNA detection plate system for detection of cytomegalovirus in clinical specimens
Abstract
With the availability of anticytomegalovirus (CMV) therapeutic agents, rapid detection of CMV is important in the care and management of the immunosuppressed patient. The PrimeCapture CMV DNA Detection Plate System (PC-PCR) was evaluated for the detection of CMV in blood and cerebrospinal fluid (CSF). The resolution of discordant results was performed by consensus testing utilizing a combination of conventional cell culture (TC-CPE), the CMV-antigenemia (CMV-Ag) assay, one or more in-house CMV nested PCR assays, and/or patient evaluation and follow-up. Of 51 blood specimens from 34 patients, 23 (45%) were identified as true positives. PC-PCR was significantly more sensitive than the CMV-Ag assay, TC-CPE, or a combination of both tests. The sensitivities, specificities, positive predictive values (PPV), and negative predictive values (NPV) for PC-PCR, the CMV-Ag assay, TC-CPE, and a combination of CMV-Ag and TC-CPE were 78, 75, 72, 81%; 46, 100, 100, 70%; 39, 100, 100, 67%; and 58, 100, 100, 73%, respectively. CMV was not detected or isolated in CSF, resulting in a combined PC-PCR sensitivity, specificity, PPV, and NPV of 77, 90, 68, and 93%, respectively. Among those laboratorians considering the incorporation of molecular CMV diagnostics into their clinical microbiology or virology laboratories, the CMV PC-PCR offers a relatively simple-to-perform and sensitive assay system.
Similar articles
-
Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.J Clin Virol. 2005 Jun;33(2):138-44. doi: 10.1016/j.jcv.2004.09.032. Epub 2004 Dec 16. J Clin Virol. 2005. PMID: 15911429
-
Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.J Clin Microbiol. 2001 Nov;39(11):3938-41. doi: 10.1128/JCM.39.11.3938-3941.2001. J Clin Microbiol. 2001. PMID: 11682510 Free PMC article.
-
Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.Clin Transplant. 1997 Aug;11(4):286-93. Clin Transplant. 1997. PMID: 9267717
-
Use of the cytomegalovirus antigenemia (CMV-Ag) assay for the detection of CMV in the blood of AIDS patients.Can J Microbiol. 1993 Nov;39(11):1059-65. doi: 10.1139/m93-160. Can J Microbiol. 1993. PMID: 8306207
-
Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay.J Virol Methods. 2007 Dec;146(1-2):147-54. doi: 10.1016/j.jviromet.2007.06.013. Epub 2007 Jul 27. J Virol Methods. 2007. PMID: 17673304
Cited by
-
Leukocyte concentration in the performance of the pp65 antigenemia assay.J Clin Microbiol. 2000 Aug;38(8):3137-8. doi: 10.1128/JCM.38.8.3137-3138.2000. J Clin Microbiol. 2000. PMID: 11001666 Free PMC article. No abstract available.
References
-
- Bitsch A, Kirchner H, Dennin R, Hoyer J, Fricke L, Steinhoff J, Sack K, Bein G. The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection. Transplantation. 1993;56:108–113. - PubMed
-
- Bowen E F, Sabin C A, Wilson P, Griffiths P D, Davey C C, Johnson M A, Emery V C. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS. 1997;11:889–893. - PubMed
-
- Cranage M P, Kouzarides T, Bankier A T, Satchwell S, Weston K, Tomlinson P, Barrel B, Hart H, Bell S E, Minson A C, Smith G L. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J. 1986;5:3057–3063. - PMC - PubMed
-
- Dodt K K, Jacobson P H, Hofmann B, Meyer C, Kolmos H J, Skinhoj P, Norrild B, Mathiesen L. Development of cytomegalovirus (CMV) disease may be predicted in HIV-1 infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS. 1997;11:F21–F28. - PubMed
-
- Einsele H, Ehninger G, Steidle M, Vallbracht A, Muller M, Schmidt H, Saal J G, Waller H D, Muller C. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet. 1991;33:1170–1172. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous